Wednesday, November 25,  6:35 pm

Forward-looking intelligence allows you time to act. View this video on our restructuring content to see how you can benefit from our expertise.

The private equity owners of Switzerland's Nycomed International Management GmbH have begun considering a sale of the pharmaceutical group after larger rivals announced major deals to enter new markets and replenish drug pipelines.

Nycomed's owners, Sweden's Nordic Capital and Swiss-owned Credit Suisse DLJ Merchant Banking Partners, have tapped Goldman, Sachs & Co. to begin considering a sale or other alternatives for Nycomed, according to a source.

This is a free preview of the content available in The Deal Pipeline. Subscribers enjoy access to the full story, as well as second-to-none research tools.

To request a demo, or, if you are an existing user to The Deal Pipeline, log in to your account, please scroll down and click the button.

Dig deeper, with Pipeline.

• 145 articles related to Nordic Capital
• 66 articles related to Nycomed International Management GmbH
• 34 company pages related to Switzerland
• 10 in-depth reports of PE deals in the Healthcare sector
• 10 years of news and analysis archives from the voice of The Deal Economy
  

Most searched keywords

• Skadden Arps
• Amusement parks
• Deb Shops
• Windstream Corp.
• Diedrich Coffee
• Hanna Andersson
• Tween Brands
• Entertainment
  
• Lazard
• Lyondell Chemical